News
Roche’s Genentech Earmarks $700M for North Carolina Plant as Billion-Dollar US Pledge Hangs in Balance
The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that could change if certain yet-unspecified policies are implemented that could “harm our industry’s ability to operate and innovate in America.
The committee awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in the ...
Genentech plans to invest $700 million in a new facility in Holly Springs, North Carolina, creating 420 jobs and joining the ...
Roche envisions its Indianapolis site as a “major hub” for the manufacturing of its continuous glucose monitoring systems.
For the second time this week, North Carolina has awarded an economic incentive to a manufacturer that promises to add ...
Morristown-based Sanofi will be the latest U.S drugmaker to inject billions of dollars into domestic operations and American manufacturing.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback